Histamine receptors in the CNS as targets for therapeutic intervention
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ahlquist, 1948, A study of the adrenotropic receptors, Am. J. Physiol., 153, 586, 10.1152/ajplegacy.1948.153.3.586
Brimblecombe, 1975, The pharmacology of cimetidine, a new histamine H2-receptor antagonist, Br. J. Pharmacol., 53, 435P
Arrang, 1983, Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptors, Nature, 302, 832, 10.1038/302832a0
Arrang, 1987, Highly-potent and selective ligands for histamine-H3 receptors, Nature, 327, 117, 10.1038/327117a0
Lin, 2011, Histamine H3-receptors and sleep-wake regulation, J. Pharmacol. Exp. Ther., 336, 17, 10.1124/jpet.110.170134
Masaki, 2010, Neuronal histamine and its receptors: implication of the pharmacological treatment of obesity, Curr. Med. Chem., 17, 4587, 10.2174/092986710794182944
Selbach, 1997, Long-term increase of hippocampal excitability by histamine and cyclic AMP, Neuropharmacology, 36, 1539, 10.1016/S0028-3908(97)00144-5
Dai, 2007, Selective cognitive dysfunction in mice lacking histamine H1 and H2 receptors, Neurosci. Res., 57, 306, 10.1016/j.neures.2006.10.020
Cannon, 2007, Activation of peripheral and spinal histamine H(3) receptors inhibits formalin-induced inflammation and nociception, respectively, Pharmacol. Biochem. Behav., 88, 122, 10.1016/j.pbb.2007.07.014
Malmberg-Aiello, 1994, Role of histamine in rodent antinociception, Br. J. Pharmacol., 111, 1269, 10.1111/j.1476-5381.1994.tb14883.x
Thoburn, 1994, Histamine-induced modulation of nociceptive responses, Pain, 58, 29, 10.1016/0304-3959(94)90182-1
Bongers, 2007, Molecular aspects of the histamine H3 receptor, Biochem. Pharmacol., 73, 1195, 10.1016/j.bcp.2007.01.008
Lovenberg, 1999, Cloning and functional expression of the human histamine H3 receptor, Mol. Pharmacol., 55, 1101, 10.1124/mol.55.6.1101
Coge, 2001, Genomic organization and characterization of splice variants of the human histamine H3 receptor, Biochem. J., 355, 279, 10.1042/0264-6021:3550279
Gbahou, 2003, Protean agonism at histamine H3 receptors in vitro and in vivo, Proc. Natl. Acad. Sci. U.S.A., 100, 11086, 10.1073/pnas.1932276100
Strakhova, 2009, Localization of histamine H4 receptors in the central nervous system of human and rat, Brain Res., 1250, 41, 10.1016/j.brainres.2008.11.018
Chazot, 2009, Advances in histamine pharmacology reveal new drug targets, Br. J. Pharmacol., 157, 1, 10.1111/j.1476-5381.2009.00228.x
Moreno-Delgado, 2009, Different role of cAMP dependent protein kinase and CaMKII in H3 receptor regulation of histamine synthesis and release, Neuroscience, 164, 1244, 10.1016/j.neuroscience.2009.08.068
Torrent, 2005, H3 autoreceptors modulate histamine synthesis through calcium/calmodulin- and cAMP-dependent protein kinase pathways, Mol. Pharmacol., 67, 195, 10.1124/mol.104.005652
Morisset, 2000, High constitutive activity of native H3 receptors regulates histamine neurons in brain, Nature, 408, 860, 10.1038/35048583
Tiligada, E. et al. Histamine pharmacology and new CNS drug targets. CNS Neurosci. Ther.(in press) doi:10.1111/j.1755-5949.2010.00212.x
Blandina, 2010, Histamine neuronal system as therapeutic target for the treatment of cognitive disorders, Future Neurol., 5, 543, 10.2217/fnl.10.30
Benarroch, 2010, Histamine in the CNS: multiple functions and potential neurologic implications, Neurology, 75, 1472, 10.1212/WNL.0b013e3181f884b1
Yokota, 2008, Participation of histamine H3 receptors in experimental allergic rhinitis of mice, J. Pharmacol. Sci., 108, 206, 10.1254/jphs.08164FP
Schwartz, 1980, Histamine as a neurotransmitter in mammalian brain: neurochemical evidence, J. Neurochem., 35, 26, 10.1111/j.1471-4159.1980.tb12485.x
Panula, 1984, Histamine-containing neurons in the rat hypothalamus, Proc. Natl. Acad. Sci. U.S.A., 81, 2572, 10.1073/pnas.81.8.2572
Watanabe, 1983, Evidence for the presence of a histaminergic neuron system in the rat brain: an immunohistochemical analysis, Neurosci. Lett., 39, 249, 10.1016/0304-3940(83)90308-7
Takahashi, 2006, Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse, J. Neurosci., 26, 10292, 10.1523/JNEUROSCI.2341-06.2006
Anaclet, 2009, Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models, J. Neurosci., 18, 14423, 10.1523/JNEUROSCI.2604-09.2009
Valdés, 2010, The histaminergic tuberomammillary nucleus is critical for motivated arousal, Eur. J. Neurosci., 31, 2073, 10.1111/j.1460-9568.2010.07241.x
Passani, 2007, Histamine in the brain: beyond sleep and memory, Biochem. Pharmacol., 73, 1113, 10.1016/j.bcp.2006.12.002
Köhler, 1985, The cytoarchitecture, histochemistry and projections of the tuberomammillary nucleus in the rat, Neuroscience, 16, 85, 10.1016/0306-4522(85)90049-1
Giannoni, 2009, Heterogeneity of histaminergic neurons in the tuberomammillary nucleus of the rat, Eur. J. Neurosci., 29, 2363, 10.1111/j.1460-9568.2009.06765.x
Kay, 1997, Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance, Arch. Intern. Med., 157, 2350, 10.1001/archinte.1997.00440410082009
Moree, 2010, Novel benzothiophene H1-antihistamines for the treatment of insomnia, Bioorg. Med. Chem. Lett., 20, 2316, 10.1016/j.bmcl.2010.01.134
Moree, 2010, Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia, Bioorg. Med. Chem. Lett., 20, 5874, 10.1016/j.bmcl.2010.07.117
Lavrador-Erb, 2010, The discovery and structure-activity relationships of 2-(piperidin-3-yl)-1H-benzimidazoles as selective, CNS penetrating H1-antihistamines for insomnia., Bioorg. Med. Chem. Lett., 20, 2916, 10.1016/j.bmcl.2010.03.027
Korotkova, 2007, Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors, Neuropharmacology, 52, 626, 10.1016/j.neuropharm.2006.09.005
Parmentier, 2007, The brain H(3)-receptor as a novel therapeutic target for vigilance and sleep-wake disorders, Biochem. Pharmacol., 73, 1157, 10.1016/j.bcp.2007.01.002
Ligneau, 2007, BF2.649, a non-imidazole inverse agonist/antagonist at the human histamine H3-receptor: preclinical pharmacology, J. Pharmacol. Exp. Ther., 320, 365, 10.1124/jpet.106.111039
Lin, 2008, An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin−/− mice and patients, Neurobiol. Dis., 30, 74, 10.1016/j.nbd.2007.12.003
Arnulf, 2009, Results of clinical trials of tiprolisant in narcolepsy and Parkinson's disease, Eur. Neuropsychopharmacol., 19, S204, 10.1016/S0924-977X(09)70268-8
Ondo, 2005, Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial, J. Neurol. Neurosurg. Psychiatry, 76, 1636, 10.1136/jnnp.2005.065870
Guo, 2009, Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox−/− mice, Br. J. Pharmacol., 157, 104, 10.1111/j.1476-5381.2009.00205.x
Bartus, 2000, On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis, Exp. Neurol., 163, 495, 10.1006/exnr.2000.7397
Passani, 2004, The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders, Trends Pharmacol. Sci., 25, 618, 10.1016/j.tips.2004.10.003
Brioni, 2011, Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease, J. Pharmacol. Exp. Ther., 336, 38, 10.1124/jpet.110.166876
Medhurst, 2007, GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models, J. Pharmacol. Exp. Ther., 321, 1032, 10.1124/jpet.107.120311
Bonaventure, 2007, Histamine H3 receptor antagonists: from target identification to drug leads, Biochem. Pharmacol., 73, 1084, 10.1016/j.bcp.2006.10.031
Goldman-Rakic, 2004, Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction, Psychopharmacology (Berlin), 174, 3, 10.1007/s00213-004-1793-y
Southam, 2009, Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040, Psychopharmacology (Berlin), 201, 483, 10.1007/s00213-008-1310-9
Iannone, 2010, Acute alertness-promoting effects of a novel histamine subtype-3 receptor inverse agonist in healthy sleep-deprived male volunteers, Clin. Pharmacol. Ther., 88, 831, 10.1038/clpt.2010.205
Nathan, P.J. et al. Neuropsychiatric adverse effects of centrally acting antiobesity drugs. CNS Neurosci Ther.(in press) doi:10.1111/j.1755-5949.2010.00172.x
Masaki, 2006, The hypothalamic H1 receptor: a novel therapeutic target for disrupting diurnal feeding rhythm and obesity, Trends Pharmacol. Sci., 27, 279, 10.1016/j.tips.2006.03.008
Passani, 2011, The histamine H3 receptor and eating behavior, J. Pharmacol. Exp. Ther., 336, 24, 10.1124/jpet.110.171306
Masaki, 2004, Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity, Diabetes, 53, 2250, 10.2337/diabetes.53.9.2250
Passani, M.B. et al. (2009) Oleoylethanolamide modulates histamine release in selected brain regions. 38th Annual Meeting of the Society for Neuroscience, 17th–21st October, Chicago Il (Abs. 87)
Malmlöf, 2005, Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight, Int. J. Obes. (Lond.), 29, 1402, 10.1038/sj.ijo.0803036
Panula, 2011, Histamine and H3 receptor in alcohol-related behaviors, J. Pharmacol. Exp. Ther., 336, 9, 10.1124/jpet.110.170928
Galici, R. et al. JNJ-39220675, a novel selective histamine H(3) receptor antagonist, reduces the abuse-related effects of alcohol in rats. Psychopharmacology (Berlin).(in press) doi:10.1007/s00213-010-2092-4
Musio, 2006, A key regulatory role for histamine in experimental autoimmune encephalomyelitis: disease exacerbation in histidine decarboxylase-deficient mice, J. Immunol., 176, 17, 10.4049/jimmunol.176.1.17
Mariottini, 2009, Activation of the histaminergic H3 receptor induces phosphorylation of the Akt/GSK-3 beta pathway in cultured cortical neurons and protects against neurotoxic insults, J. Neurochem., 110, 1469, 10.1111/j.1471-4159.2009.06249.x
Bitner, 2011, In-vivo histamine H(3) receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer's disease, Neuropharmacology, 60, 460, 10.1016/j.neuropharm.2010.10.026